Trial Profile
A trial to compare the use of solifenacin and fesoterodine in treatment of overactive bladder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 May 2016
Price :
$35
*
At a glance
- Drugs Fesoterodine (Primary) ; Solifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 04 May 2016 New trial record